Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Angela DeLuca"'
Autor:
Philip Komarnitsky, Matthew W. Dudley, Dustin A. Deming, Samuel Y Ngan, Brian G. Czito, Lei He, Mary F. Mulcahy, Wijith Munasinghe, Angela DeLuca, John Zalcberg, Kyle D. Holen, Rajendar K. Mittapalli, Michael Michael, Houman Vaghefi, Gayle S. Jameson
Publikováno v:
The Lancet Gastroenterology & Hepatology. 2:418-426
Summary Background Further optimisation of present standard chemoradiation is needed in patients with locally advanced rectal cancer. Veliparib, an oral poly(ADP-ribose) polymerase inhibitor, has been shown to enhance the antitumour activity of chemo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e0c3298d5aff4be85deed3990e6975d
https://doi.org/10.1016/s2468-1253(17)30012-2
https://doi.org/10.1016/s2468-1253(17)30012-2
Autor:
Franca, Giacchino, Giorgina, Piccoli, Loredana, Colla, Roberta, Fenoglio, Federico, Marazzi, Alessandro, Amore, Cristiana, Rollino, Piero, Stratta, Carmela, Vella Maria, Angela, Deluca, Roberto, Boero, Doriana, Chiarinotti, Carolina, Licata, Raffaella, Cravero, Serena, Bainotti, Massimo, Manes, Cristina, Marcuccio, Brigida, Brezzi, Mariano, Filippo, Eugenia, Pignone, Roberto, Reinero, Elisabetta, Radin, Michela, Tamagnone
The Piedmont Group of Clinical Nephrology compared the activity of 18 nephrology centers in Piedmont and Aosta Valley as regards acute pielonephritis (APN). Data from more than 500 cases per year of APN were examined. The microbial spectrum of APN co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::eface81e9d925bbde62216ced436af09
http://hdl.handle.net/2318/148583
http://hdl.handle.net/2318/148583
Autor:
Patrizia Luppi, Angela DeLuca, Vincenza Cifarelli, Ingrid Libman, Massimo Trucco, Dorothy J. Becker
AIM: Compelling evidence implicates inflammation in the pathogenesis of type 1 diabetes mellitus (T1DM) and associated vascular complications. Obesity is also characterized by low-grade systemic inflammation. In this study, we characterized the infla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf60a68fa4e0043b9e5c1e1e61f8c8bd
https://europepmc.org/articles/PMC2040113/
https://europepmc.org/articles/PMC2040113/
Autor:
Mary F. Mulcahy, Philip Komarnitsky, Angela DeLuca, Matthew W. Dudley, Hao Xiong, Dustin A. Deming, Michael Michael, Brian G. Czito, Houman Vaghefi, Wijith Munasinghe, Kyle D. Holen, G. Jameson
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 93:S206
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::79d4ded20797ac0d52563de1f7f710b0
https://doi.org/10.1016/j.ijrobp.2015.07.494
https://doi.org/10.1016/j.ijrobp.2015.07.494
Autor:
Philip Clingan, Krzysztof Leśniewski-Kmak, Suresh S. Ramalingam, Caroline Nickner, Salih Zeki Guclu, Angela DeLuca, Laszlo Urban, Vincent L. Giranda, Julien Mazieres, Qin Qin, Igor Bondarenko, Vera Gorbunova, Mark D. McKee, Michelle Pedersen
Publikováno v:
Journal of Clinical Oncology. 33:TPS8107-TPS8107
TPS8107 Background: NSCLC is often diagnosed at an advanced stage, conferring a poor prognosis. The current standard of care for first-line treatment comprises platinum-based regimens. Veliparib is...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b0b2f0f08a423908debbb15c1a21297
https://doi.org/10.1200/jco.2015.33.15_suppl.tps8107
https://doi.org/10.1200/jco.2015.33.15_suppl.tps8107
Autor:
Kyle D. Holen, Gayle S. Jameson, Mary F. Mulcahy, Brian G. Czito, Wijith Munasinghe, Houman Vaghefi, Hao Xiong, Angela DeLuca, Matthew W. Dudley, Michael Michael, Dustin A. Deming, Philip Komarnitsky
Publikováno v:
Journal of Clinical Oncology. 33:3517-3517
3517 Background: Standard treatment for patients (pts) with LARC consists of chemoradiation followed by surgery. To achieve higher response rates and reduce risk of recurrence, further optimization...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1dcf983696622ab2682ae052f44ef8b3
https://doi.org/10.1200/jco.2015.33.15_suppl.3517
https://doi.org/10.1200/jco.2015.33.15_suppl.3517
Autor:
Angela DeLuca, Michelle Pedersen, Jade Irving, Terri Leahy, Qin Qin, Vincent L. Giranda, Courtney Caskey, Mark D. McKee, Peter Ansell, Jane Qian
Publikováno v:
Journal of Clinical Oncology. 33:TPS8106-TPS8106
TPS8106 Background: Standard chemotherapy for patients (pts) with metastatic NSq NSCLC consists of 4−6 cycles of platinum-based doublet therapy +/– subsequent maintenance monotherapy. Clinical outc...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b8e2447dd4859687c0b811f34344df45
https://doi.org/10.1200/jco.2015.33.15_suppl.tps8106
https://doi.org/10.1200/jco.2015.33.15_suppl.tps8106
Autor:
Mary F. Mulcahy, Dustin A. Deming, Brian G. Czito, Kyle D. Holen, Angela DeLuca, Matthew W. Dudley, Hao Xiong, Michael Michael, Wijith Munasinghe, Houman Vaghefi, Gayle S. Jameson, Philip Komarnitsky
Publikováno v:
Journal of Clinical Oncology. 33:579-579
579 Background: Patients (pts) with LARC treated with neoadjuvant C/RT and then surgery have low rates of pathologic complete response (ypCR) and significant relapse rates. V is a potent, orally bioavailable PARP inhibitor that has been shown to enha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::35480e657aba3a90f2bcd1a621c011b8
https://doi.org/10.1200/jco.2015.33.3_suppl.579
https://doi.org/10.1200/jco.2015.33.3_suppl.579
Autor:
Angela DeLuca, Michael Michael, W. Schelman, Houman Vaghefi, Kyle D. Holen, J. Gayle, Mary F. Mulcahy, Hao Xiong, Brian G. Czito, D. Matthew, Wijith Munasinghe
Publikováno v:
Journal of Clinical Oncology. 32:3634-3634
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da5ba07c81c5b147d157ba04db5234bb
https://doi.org/10.1200/jco.2014.32.15_suppl.3634
https://doi.org/10.1200/jco.2014.32.15_suppl.3634